<![CDATA[Advances in Immunotherapy for Breast Cancer]]>
Introduction Breast cancer is the most commonly diagnosed malignancy in women, with more than 2.3 million new cases in 2022.1 Historically, breast cancer was treated with cytotoxic chemotherapy and was initially thought to be less responsive to immunologic …